Morgan Stanley Maintains Equal Weight on Phibro Animal Health Corporation (PAHC), Cites Margin Expansion
TheFly reported on February 6 that Morgan Stanley increased its price target on PAHC to $49 from $45 and maintained an Equal Weight rating.
Phibro Animal Health Corp (PAHC)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 641,313 | $23,959,454 | +4228% | 0.01% |
| 2. | Renaissance Technologies Jim Simons | 545,300 | $20,372,408 | -2% | 0.03% |
| 3. | Ranger Investment Management Conrad Doenges (Cio) | 279,425 | $10,439,318 | -7% | 0.72% |
| 4. | CastleKnight Management Aaron Weitman | 240,897 | $8,999,912 | -40% | 0.2% |
| 5. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 201,729 | $7,536,595 | -34% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $22.10 | 5,000 | $110,500.00 | 30,000 | 2025-02-24 | Filing | |
| $20.02 | 5,000 | $100,100.00 | 25,000 | 2024-09-04 | Filing | |
| $23.68 | 5,000 | $118,400.00 | 20,000 | 2021-08-30 | Filing | |
| $21.21 | 5,000 | $106,050.00 | 15,000 | 2019-08-30 | Filing | |
| $18.14 | 5,000 | $90,700.00 | 10,000 | 2016-05-19 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $54.56 | 421 | $22,969.00 | 95,880 | 2026-04-23 | Filing | |
| $54.07 | 6,619 | $357,856.90 | 96,301 | 2026-04-23 | Filing | |
| $54.29 | 7,040 | $382,184.70 | 102,920 | 2026-04-22 | Filing | |
| $56.17 | 5,415 | $304,136.72 | 109,960 | 2026-04-21 | Filing | |
| $55.35 | 1,625 | $89,943.91 | 115,375 | 2026-04-21 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 267,045 | $14,770,259 | 2.3% | |
| 2. | 99,026 | $5,477,129 | 0.71% | |
| 3. | 69,643 | $3,851,954 | 2.65% | |
| 4. | 53,560 | $2,962,404 | 0.37% | |
| 5. | 49,019 | $2,711,241 | 0.1% |
News See All
7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds
According to research, the U.S.
Phibro Animal Health Corporation (NASDAQ:PAHC) Q2 2026 Earnings Call Transcript
Operator: Hello and thank you for standing by. My name is Regina, and I will be your conference operator today.
10 Hottest Small Cap Stocks to Buy Now
On November 12, Scott Chronert, Citi's U.S. equity strategist, appeared on a CNBC Television interview to discuss his bullish case for small- and mid-cap stocks.
Phibro Animal Health Corporation (NASDAQ:PAHC) Q1 2026 Earnings Call Transcript
Operator: Hello, and thank you for standing by. Welcome to the Phibro Animal Health Corporation First Quarter 2026 Webcast and Conference Call.
Phibro Animal Health Corporation (PAHC) Soars 39% in Q4, Stock Up 80% YTD on Zoetis Acquisition Boost
Phibro Animal Health Corporation (NASDAQ:PAHC) reported strong growth in 2025, driven by expanded product lines and rising global demand.
12 Healthcare Stocks with Insider Buying in 2025
In 2025, there will be a complicated combination of opportunities and difficulties in the healthcare innovation landscape, with divergent trends in technology adoption, investment, and fundraising.
Phibro Animal Health Corporation (NASDAQ:PAHC) Q4 2025 Earnings Call Transcript
Operator: Hello, and thank you for standing by. My name is Regina, and I will be your conference operator today.
Phibro Animal Health Corporation (NASDAQ:PAHC) Q3 2025 Earnings Call Transcript
Operator: Hello and thank you for standing by. My name is Regina [ph] and I will be your conference operator today.
Phibro Animal Health Corporation (NASDAQ:PAHC) Q2 2025 Earnings Call Transcript
Operator: Hello, and thank you for standing by. My name is Regina, and I will be your conference operator today.
Hedge Fund Resource Center